{"text": ["Eli", "Lilly", "(LLY)", "Flat", "As", "Market", "Gains:", "What", "You", "Should", "Know"], "created_at": "2019-03-12 21:50:09"}
{"text": ["Eli", "Lilly\u2019s", "Latest", "Move", "Proves", "the", "American", "Healthcare", "System", "Is", "Broken"], "created_at": "2019-03-12 19:06:19"}
{"text": ["Eli", "Lilly\u2019s", "Latest", "Move", "Proves", "the", "American", "Healthcare", "System", "Is", "Broken"], "created_at": "2019-03-12 19:06:19"}
{"text": ["BioNtech", "hires", "banks", "for", "IPO", "worth", "up", "to", "$800", "million", "-", "sources"], "created_at": "2019-03-12 18:06:17"}
{"text": ["Biontech", "stock", "offering", "could", "be", "worth", "as", "much", "as", "$800", "million-sources"], "created_at": "2019-03-12 17:29:48"}
{"text": ["Allergan", "Announces", "FDA", "Acceptance", "of", "Migraine", "Candidate", "NDA"], "created_at": "2019-03-12 16:11:52"}
{"text": ["Allergan", "Announces", "FDA", "Acceptance", "of", "Migraine", "Candidate", "NDA"], "created_at": "2019-03-12 16:11:52"}
{"text": ["Eli", "Lilly", "Could", "Sustain", "Industry-Leading", "Growth,", "Says", "Bullish", "JPMorgan"], "created_at": "2019-03-12 16:10:31"}
{"text": ["Eli", "Lilly\u2019s", "Latest", "Move", "Proves", "the", "American", "Healthcare", "System", "Is", "Broken"], "created_at": "2019-03-12 14:46:09"}
{"text": ["See", "what", "the", "IHS", "Markit", "Score", "report", "has", "to", "say", "about", "Eli", "Lilly", "and", "Co."], "created_at": "2019-03-12 14:24:50"}
{"text": ["Allergan", "Announces", "FDA", "Acceptance", "of", "Migraine", "Candidate", "NDA"], "created_at": "2019-03-12 14:20:02"}
{"text": ["Why", "Eli", "Lilly", "Stock", "Fell", "Yesterday"], "created_at": "2019-03-12 12:15:36"}
{"text": ["Here", "are", "the", "biggest", "analyst", "calls", "of", "the", "day:", "Tesla,", "Boeing,", "Coca-Cola,", "Monster", "Beverage,", "Eli", "Lilly"], "created_at": "2019-03-12 11:33:56"}
{"text": ["Here", "are", "the", "biggest", "analyst", "calls", "of", "the", "day:", "Tesla,", "Boeing,", "Coca-Cola,", "Monster", "Beverage,", "Eli", "Lilly"], "created_at": "2019-03-12 11:33:56"}
{"text": ["Lilly's", "combo", "therapy", "succeeds", "in", "late-stage", "lung", "cancer", "study"], "created_at": "2019-03-12 11:18:02"}
{"text": ["Lilly's", "combo", "treatment", "meets", "main", "goal", "in", "lung", "cancer", "late-stage", "study"], "created_at": "2019-03-12 10:55:23"}
{"text": ["Lilly's", "CYRAMZA\u00ae", "(ramucirumab)", "Phase", "3", "RELAY", "Trial", "Met", "Primary", "Endpoint,", "Significantly", "Improving", "Progression-Free", "Survival", "in", "First-Line", "Treatment", "of", "Patients", "with", "Metastatic", "EGFR-Mutated", "Non-Small", "Cell", "Lung", "Cancer"], "created_at": "2019-03-12 10:45:00"}
{"text": ["Dicerna", "Pharmaceuticals", "Inc", "(DRNA)", "Q4", "2018", "Earnings", "Conference", "Call", "Transcript"], "created_at": "2019-03-12 01:28:07"}
